T4	Treatment 69 93	intravitreal ranibizumab
T5	Effect 12 52	Severe and sustained ocular hypertension
T6	Drug 82 93	ranibizumab
T7	Route 69 81	intravitreal
T8	Speculation_cue 53 56	may
T9	Severity_cue 12 32	Severe and sustained
T3	Adverse_event 63 68	after
E1	Adverse_event:T3 
A1	Severity E1 High